サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1542526

AAV受託開発・製造機関の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global AAV Contract Development And Manufacturing Organizations Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 171 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
AAV受託開発・製造機関の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 171 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

AAV受託開発・製造機関市場の世界需要は、2023年の6億8,398万米ドルから2032年には約29億9,921万米ドルの市場規模に達すると推定され、調査期間2024～2032年のCAGRは17.85%です。

AAV（アデノ随伴ウイルス）開発製造受託機関（CDMO）は、AAVベースの遺伝子治療の開発、製造、試験を専門とする企業です。AAVは小型の非病原性ウイルスで、遺伝子治療における遺伝子導入用ベクターとして一般的に使用されています。AAV CDMOは顧客と協力して、特定の治療用途にAAVベクターを設計し、最適化します。また、細胞株の開発、ベクター生産プロセスの最適化、最終製品の精製と特性評価など、AAVベクターの生産に関するサービスも提供しています。さらに、AAV CDMOは、力価、純度、無菌性、同一性のテストを含む、安全性と有効性を確保するためのAAVベクターの厳格なテストを実施しています。

市場力学

より多くの遺伝子治療製品が臨床使用を承認されるにつれ、遺伝子治療市場は急速に拡大しています。AAVベクターは遺伝子治療デリバリーの一般的な選択肢であり、遺伝子治療に対する需要の増加がAAV CDMO市場の成長を牽引しています。AAVベクター技術の進歩は、ベクター生産プロセスの改善、導入効率の向上、免疫反応の低減につながっています。このような進歩により、AAVベクターは遺伝子治療用途にとってより魅力的なものとなり、AAV CDMOサービスの需要が高まっています。遺伝子治療研究への資金提供は近年著しく増加しており、政府機関、民間投資家、非営利団体などが遺伝子治療市場の成長に貢献しています。このような資金調達が新たな遺伝子治療の開発を促進し、ひいてはAAV CDMOサービスの需要を高めています。FDAのような規制機関は遺伝子治療の開発を支持し、遺伝子治療製品の迅速な承認経路を導入しています。こうした規制当局の支援が、AAV CDMO市場を含む遺伝子治療市場の成長を後押ししています。多くのバイオテクノロジー企業や製薬会社は、高価な自社施設に投資するよりも、遺伝子治療薬の製造を専門のCDMOに委託することを選択しています。この動向により、遺伝子治療製品の開発・製造を支援する経験豊富なパートナーを求める企業が増え、AAV CDMOサービスの需要が高まっています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、AAV受託開発・製造組織の世界市場における各セグメントを包括的に評価することもできます。AAV受託開発・製造機関業界の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

AAV受託開発・製造機関市場レポートのこのセクションでは、国および地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後の機会を支援します。

ワークフロー別

  • アップストリーム処理（ベクター増幅・展開、ベクター回収・採取）
  • ダウンストリーム処理（精製、充填仕上げ）

培養タイプ別

  • 付着培養
  • 懸濁培養

用途別

  • 細胞・遺伝子治療開発
  • ワクチン開発
  • バイオ医薬品・創薬
  • バイオメディカル調査

エンドユーザー別

  • 製薬・バイオ医薬品企業
  • 学術・研究機関

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるAAV受託開発・製造機関市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 AAV受諾開発・製造機関- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 AAV受託開発・製造機関の世界市場分析：ワークフロー別

  • ワークフロー別概要
  • 実績データと予測データ
  • ワークフロー別分析
  • 上流工程（ベクター増幅・展開、ベクター回収・採取）
  • ダウンストリーム処理（精製、充填仕上げ）

第6章 世界のAAV受託開発・製造機関市場分析：培養タイプ別

  • 培養タイプ別概要
  • 実績データと予測データ
  • 培養タイプ別分析
  • 付着培養
  • 懸濁培養

第7章 世界のAAV受託開発・製造機関市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 細胞・遺伝子治療開発
  • ワクチン開発
  • バイオ医薬品・創薬
  • バイオメディカル研究

第8章 医薬品開発・製造受託機関の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 製薬・バイオ医薬品企業
  • 学術・研究機関

第9章 医薬品開発・製造受託機関の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 AAV受託開発・製造機関企業の競合情勢

  • AAV受託開発・製造機関の市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fischer Scientific Inc.
  • Creative Biogene
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Danaher（Aldevron）
  • Forge Biologics
  • Genezen
  • ViroCell Biologics
  • Merck KGaA
  • Viralgen
  • Biovian Oy
  • Esco Lifesciences（Esco Aster Pte. Ltd.）
  • GenScript ProBio
  • Porton Advanced Solution Ltd
  • Ask Bio
  • Showa Denko
  • Takara Bio Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Workflow (USD MN)
  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales By Geography (USD MN)
  • Downstream Processing (Purification, Fill Finish) Market Sales By Geography (USD MN)
  • Analysis By Culture Type (USD MN)
  • Adherent Culture Market Sales By Geography (USD MN)
  • Suspension Culture Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cell & Gene Therapy Development Market Sales By Geography (USD MN)
  • Vaccine Development Market Sales By Geography (USD MN)
  • Biopharmaceutical & Pharmaceutical Discovery Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global AAV Contract Development And Manufacturing Organizations Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of AAV Contract Development And Manufacturing Organizations Report
  • Market Research Process
  • Market Research Methodology
  • Global AAV Contract Development And Manufacturing Organizations Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Culture Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Workflow (USD MN)
  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales By Geography (USD MN)
  • Downstream Processing (Purification, Fill Finish) Market Sales By Geography (USD MN)
  • Global Market Analysis By Culture Type (USD MN)
  • Adherent Culture Market Sales By Geography (USD MN)
  • Suspension Culture Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cell & Gene Therapy Development Market Sales By Geography (USD MN)
  • Vaccine Development Market Sales By Geography (USD MN)
  • Biopharmaceutical & Pharmaceutical Discovery Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112110635

The global demand for AAV Contract Development And Manufacturing Organizations Market is presumed to reach the market size of nearly USD 2999.21 Million by 2032 from USD 683.98 Million in 2023 with a CAGR of 17.85% under the study period 2024 - 2032.

AAV (adeno-associated virus) Contract Development and Manufacturing Organizations (CDMOs) are companies that specialize in the development, manufacturing, and testing of AAV-based gene therapies. AAV is a small, non-pathogenic virus that is commonly used as a vector for gene delivery in gene therapy. AAV CDMOs work with clients to design and optimize AAV vectors for specific therapeutic applications. They also provide services for the production of AAV vectors, including the development of cell lines, optimization of vector production processes, and purification and characterization of the final product. In addition, AAV CDMOs conduct rigorous testing of the AAV vectors to ensure safety and efficacy, including tests for potency, purity, sterility, and identity.

MARKET DYNAMICS

The market for gene therapies is expanding rapidly as more gene therapy products are approved for clinical use. AAV vectors are a popular choice for gene therapy delivery, and the increasing demand for gene therapies is driving growth in the AAV CDMO market. Advances in AAV vector technology have led to improved vector production processes, increased transduction efficiency, and reduced immune responses. These advances have made AAV vectors more attractive for gene therapy applications and have increased the demand for AAV CDMO services. The availability of funding for gene therapy research has increased significantly in recent years, with government agencies, private investors, and non-profit organizations all contributing to the gene therapy market growth. This funding is driving the development of new gene therapies, which in turn is increasing demand for AAV CDMO services. Regulatory agencies such as the FDA have shown support for the development of gene therapies and have implemented expedited approval pathways for gene therapy products. This regulatory support is helping to drive growth in the gene therapy market, including the AAV CDMO market. Many biotech and pharma companies are choosing to outsource their gene therapy manufacturing to specialized CDMOs rather than investing in expensive in-house facilities. This trend is increasing demand for AAV CDMO services as these companies seek out experienced partners to help them develop and manufacture their gene therapy products.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of AAV Contract Development And Manufacturing Organizations. The growth and trends of AAV Contract Development And Manufacturing Organizations industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the AAV Contract Development And Manufacturing Organizations market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Workflow

  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting)
  • Downstream Processing (Purification, Fill Finish)

By Culture Type

  • Adherent Culture
  • Suspension Culture

By Application

  • Cell & Gene Therapy Development
  • Vaccine Development
  • Biopharmaceutical & Pharmaceutical Discovery
  • Biomedical Research

By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the AAV Contract Development And Manufacturing Organizations market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the AAV Contract Development And Manufacturing Organizations market include Thermo Fischer Scientific Inc., Creative Biogene, Catalent Inc., Charles River Laboratories International Inc., Danaher (Aldevron), Forge Biologics, Genezen, ViroCell Biologics, Merck KGaA, Viralgen, Biovian Oy, Esco Lifesciences (Esco Aster Pte. Ltd.), GenScript ProBio, Porton Advanced Solution Ltd, Ask Bio, Showa Denko, Takara Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Workflow
    • 3.7.2 Market Attractiveness Analysis By Culture Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY WORKFLOW

  • 5.1. Overview By Workflow
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Workflow
  • 5.4. Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Historic and Forecast Sales By Regions
  • 5.5. Downstream Processing (Purification, Fill Finish) Historic and Forecast Sales By Regions

6. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY CULTURE TYPE

  • 6.1. Overview By Culture Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Culture Type
  • 6.4. Adherent Culture Historic and Forecast Sales By Regions
  • 6.5. Suspension Culture Historic and Forecast Sales By Regions

7. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cell & Gene Therapy Development Historic and Forecast Sales By Regions
  • 7.5. Vaccine Development Historic and Forecast Sales By Regions
  • 7.6. Biopharmaceutical & Pharmaceutical Discovery Historic and Forecast Sales By Regions
  • 7.7. Biomedical Research Historic and Forecast Sales By Regions

8. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-User
  • 8.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.5. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS COMPANIES

  • 10.1. AAV Contract Development And Manufacturing Organizations Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fischer Scientific Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Creative Biogene
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Catalent Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Charles River Laboratories International Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Danaher (Aldevron)
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Forge Biologics
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Genezen
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. ViroCell Biologics
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Merck KGaA
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Viralgen
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Biovian Oy
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Esco Lifesciences (Esco Aster Pte. Ltd.)
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. GenScript ProBio
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Porton Advanced Solution Ltd
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Ask Bio
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Showa Denko
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. Takara Bio Inc
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies